# Synaptojanin-1 supports VPS35-dependent trafficking of dopamine D2 autoreceptors at presynaptic terminals

**Authors:** Nirmal Kumar, Elnaz Khezerlou, Justin Cai, Hanna Caiola, Ulrik Gether, Huaye Zhang, Ping-Yue Pan

PMC · DOI: 10.21203/rs.3.rs-7730224/v1 · Research Square · 2025-10-15

## TL;DR

This paper reveals how two genes linked to Parkinson's disease work together to control dopamine receptor trafficking at synapses, offering new insights into early synaptic dysfunction in the disease.

## Contribution

The study identifies a novel functional interaction between Synaptojanin1 and VPS35 in regulating dopamine D2 autoreceptor trafficking.

## Key findings

- Synaptojanin1 deficiency causes intracellular retention of D2S autoreceptors and impaired dopamine release.
- VPS35 is recruited to D2S-containing endosomes in a Synj1-dependent manner and can overcome Synj1 deficiency effects.
- Synj1 regulates VPS35 expression and localization in dopaminergic axons, suggesting broader roles in presynaptic cargo sorting.

## Abstract

Synaptic dysfunction is a hallmark of early Parkinson’s disease (PD), but molecular mechanisms underlying dopaminergic synaptic impairment and vulnerability remain poorly understood. Here, we identify a functional interaction between two PD genes, Synaptojanin1 and VPS35, in regulating endosomal sorting of the dopamine D2 short (D2S) autoreceptor, thereby modulating dopamine signaling. We show that Synaptojanin1 deficiency results in intracellular retention of the D2S, impaired gating of dopamine release and reduced behavioral responsiveness to a D2-like agonist. VPS35 is recruited to D2S-containing and Rab7a-positive endosomes in a Synj1-dependent manner, and VPS35 overexpression overcomes Synj1 deficiency-associated impairment in D2S surface delivery in axons. Moreover, Synj1 regulates VPS35 expression and localization in dopaminergic axons, indicating their broader roles in presynaptic cargo sorting. These findings reveal a novel cooperation between a synaptic vesicle endocytic regulator and a core component of the retromer complex, providing new mechanistic insights into presynaptic trafficking and its disruption in PD.

## Linked entities

- **Genes:** VPS35 (VPS35 retromer complex component) [NCBI Gene 55737]
- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Genes:** VPS35 (VPS35 retromer complex component) [NCBI Gene 55737] {aka MEM3, PARK17}, SYNJ1 (synaptojanin 1) [NCBI Gene 8867] {aka DEE53, EIEE53, INPP5G, PARK20}, RAB7A (RAB7A, member RAS oncogene family) [NCBI Gene 7879] {aka CMT2B, PRO2706, RAB7}
- **Diseases:** PD (MESH:D010300)
- **Chemicals:** dopamine (MESH:D004298)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12633164/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12633164/full.md

## References

114 references — full list in the complete paper: https://tomesphere.com/paper/PMC12633164/full.md

---
Source: https://tomesphere.com/paper/PMC12633164